A muticentre, randomised, double-blind, placebo-controlled phase 3b trial evaluating the safety and efficacy of gefapixant 45 mg twice daily in reducing the frequency of CSUI in women, aged ≥ 18 years ...

The girl has suffered from chronic UTIs since the age of 8, with symptoms including painful urination, needing to urinate ...

Study demonstrates superior biocompatibility and mechanical performance of the Plielle™ urethral support system. For ...

A new database targeting chronic urinary tract infections (UTIs)—a long-overlooked condition that may begin in childhood—is set to help researchers uncover why millions of women and girls worldwide ...

Urinary incontinence is one of the most common problems which affect millions of people globally, across different ages and lifestyles. It entails the release of urine, which is not controlled, thus ...

Add Yahoo as a preferred source to see more of our stories on Google. Urinary incontinence, or a loss of bladder control, affects up to one-third of women in the U.S. And women are twice as likely to ...

Urge urinary incontinence may affect death risk regardless of sex and age, a US study finds. Urge urinary incontinence is associated with greater mortality risk among adults in the United States, ...

For men facing stress urinary incontinence, the lack of bladder control can be a real impediment to their daily lives. Urologist and surgeon Benjamin McCormick, MD, explains what an AUS device is, how ...

NEWTON, Mass.--(BUSINESS WIRE)--Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, today announced it has entered into a collaboration with Mayo Clinic to ...

A 12-year study examines long-term urinary incontinence after OASIS and vaginal birth. Learn how symptoms and quality of life change over time. Read more.

Their shared dedication reflects a broader mission to bring meaningful change to women’s health, offering hope and tangible ...